Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cuilin Shi"'
Autor:
Jianping Zhang, Yian Liu, Wei Lei, Junheng Shen, Jing Lu, Tao Tao, Xu Cao, Zhong Yang, Jianan Huang, Cuilin Shi
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract We examined the efficacy and safety of Liushen pill combined with basic treatment for patients with COVID‐19. In total, 181 patients hospitalized with COVID‐19, classified as asymptomatic mild type, were randomly divided into the experim
Externí odkaz:
https://doaj.org/article/3f6f1f65ec354d99bd9ff346d9f533a8
Autor:
Peijun Tang, Xingnian Chen, Junchi Xu, Yunlong Hu, Zhijian Ye, Xiafang Wang, Yumei Xiao, Xinghua Shen, Jianping Zhang, Yanjun Feng, Cuilin Shi, Xin Yu, Lixian Yi, Xinchun Chen, Binfeng Lu, Ping Xu, Zhongwen Sun, Meiying Wu
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Objective. Multidrug-resistant tuberculosis (MDR-TB) causes persistent infection and challenges tuberculosis control worldwide. T cell-mediated immunity plays a critical role in controlling Mycobacterium tuberculosis (Mtb) infection, and therefore, e
Externí odkaz:
https://doaj.org/article/e7edf10e63a6427ab59c88d017f0f34c
Autor:
cuilin Shi, Yian Liu, Wei Lei, Junheng Shen, Jing Lu, Tao Tao, Xu Cao, Zhong Yang, Jianan Huang, Jianping Zhang
Publikováno v:
Pulmonary Circulation. 13
Objective To analyze the efficacy and safety of Liushen Pill combined with basic treatment on patients with COVID-19.Methods One-hundred-eighty-one patients hospitalized with COVID-19, classified as asymptomatic, mild type, were randomly separated in
Autor:
Yicong Bian, Liyan Miao, Cuilin Shi, Linsheng Liu, Yijun Mi, Chenrong Huang, Jun Cao, Zhijian Ye
Publikováno v:
Biochemical and Biophysical Research Communications. 497:485-491
Tuberculosis (TB) has become a global public health and social threat. As clinical first-line drugs, rifampicin and isoniazid used in combination with pyrazinamide and ethambutol (the HRZE regimen) usually induce hepatotoxicity. However, the mechanis
Autor:
Jing Liu1, Meiying Wu1, Jianping Zhang1 zhangjianping_yb@suda.edu.cn, Cuilin Shi1 18168725548@163.com
Publikováno v:
Journal of Infection in Developing Countries. May2024, Vol. 18 Issue 5, p826-828. 3p.
Autor:
Zili Zhang, She Chen, Xiaoliang Yu, Lin Li, Xing Wang, Shan Liu, Lin Ge, Qin Chen, Lu Yu, Cuilin Shi, Sudan He, Lei Xu, Zhongxu Yang, Biqi Zhou, Yun Li, Wenhui He, Zhilin Hu, Xuejun Jiang, Jun Li
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 111(43)
The receptor-interacting kinase-3 (RIP3) and its downstream substrate mixed lineage kinase domain-like protein (MLKL) have emerged as the key cellular components in programmed necrotic cell death. Receptors for the cytokines of tumor necrosis factor
Autor:
Xing Wang, Yun Li, Shan Liu, Xiaoliang Yu, Lin Li, Cuilin Shi, Wenhui He, Jun Li, Lei Xu, Zhilin Hu, Lu Yu, Zhongxu Yang, Qin Chen, Lin Ge, Zili Zhang, Biqi Zhou, Xuejun Jiang, She Chen, Sudan He
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 10/28/2014, Vol. 111 Issue 43, p15438-15443, 6p
Autor:
Tang, Peijun1,2 (AUTHOR), Chen, Xingnian1 (AUTHOR), Xu, Junchi1 (AUTHOR), Hu, Yunlong3,4 (AUTHOR), Ye, Zhijian1 (AUTHOR), Wang, Xiafang1 (AUTHOR), Xiao, Yumei1,2 (AUTHOR), Shen, Xinghua1 (AUTHOR), Zhang, Jianping1 (AUTHOR), Feng, Yanjun1 (AUTHOR), Shi, Cuilin1 (AUTHOR), Yu, Xin1 (AUTHOR), Yi, Lixian2 (AUTHOR), Chen, Xinchun4 (AUTHOR), Lu, Binfeng5 (AUTHOR), Xu, Ping1,2 (AUTHOR), Sun, Zhongwen2 (AUTHOR), Wu, Meiying1 (AUTHOR)
Publikováno v:
Journal of Immunology Research. 3/17/2022, p1-10. 10p. 1 Black and White Photograph, 7 Charts.
Publikováno v:
NewsRx COVID-19 Weekly; 3/10/2023, p19-19, 1p